Learn More
Medchemexpress LLC IRAK4-IN-20 | 1931994-80-7 | C22H25F3N4O3 | 100 MG

Supplier: Medchemexpress LLC HY150735100MG
IRAK4-IN-20 (Compound BAY-1834845) is an orally active IRAK4 inhibitor with an IC50 of 3.55 nM. It can be used for acute respiratory distress syndrome (ARDS) research. It effectively prevents acute respiratory distress syndrome in mice and decreases inflammatory cytokines secretion effectively in LPS stimulated human peripheral blood mononuclear cells (PBMC).
- Orally active IRAK4 inhibitor
- IC50 of 3.55 nM
- Used for acute respiratory distress syndrome (ARDS) research
- Decreases inflammatory cytokines secretion in LPS stimulated human PBMC
- Prevents acute respiratory distress syndrome in mice
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.